Nanophase’s Earnings Call: Record Sales, Margin Reset

Nanophase Technologies Corp ((SLSN)) has held its Q4 earnings call. Read on for the main highlights of the call.

Nanophase Technologies Corp struck a cautiously optimistic tone on its latest earnings call, balancing record sales and strategic progress against clear profitability and execution challenges. Management highlighted strong commercial momentum, a growing patent portfolio and capacity for scale, but also acknowledged margin pressure, weaker open orders and near-term disruption as it rolls out its new transformation plan.

Record Revenue Growth Masks Profitability Strain

Nanophase reported record full-year revenue of $62.1 million for 2025, up 18.6% from $51.9 million in 2024, powered by a large-scale product launch and 20 new brand partners. Despite this top-line strength, the company conceded that higher sales did not translate into higher profit dollars, underscoring inefficiencies in its operating model.

Q4 Margins and Profits Show Early Improvement

Fourth-quarter 2025 revenue was $12.5 million, roughly flat year over year, but profitability metrics improved meaningfully as gross profit rose to $3.4 million from $2.8 million. Gross margin climbed to 27% from 22%, and the quarter swung to a net profit of $163,000 versus a $558,000 loss a year earlier, suggesting early benefits from operational changes.

Flat Full-Year Gross Profit Highlights Efficiency Gap

For the full year, gross profit was essentially unchanged at $16.1 million versus $16.2 million in 2024, despite the nearly 19% revenue increase. This flat outcome signals that Nanophase has yet to capture sufficient scale benefits and that its cost structure is absorbing much of the incremental revenue.

Operational Challenges Compress Margins

Management cited several factors behind the margin squeeze, including elevated labor costs tied to extended production changeovers and downtime. Additional pressure came from product design and start-up quality costs related to a complex major launch, as well as inventory control issues such as yield volatility and related losses.

Adjusted EBITDA Remains Subscale

Adjusted EBITDA for 2025 came in at $4.2 million, representing less than 7% of revenue, around 6.8%. That level leaves considerable room for improvement relative to management’s goal of achieving double-digit EBITDA margins, making cost discipline and efficiency gains central to the company’s strategy.

Order Book and Sell-Through Signal Near-Term Softness

Nanophase ended 2025 with just under $33 million in ship-in open orders, down about 13% from $38 million a year earlier. The company also flagged weak sell-through at a large mass-market customer, contributing to a normalization of revenue and adding short-term uncertainty to demand visibility.

IP Expansion and Product Recognition Support Long-Term Story

On the strategic side, the patent portfolio expanded by 20% to more than 120 patents, reinforcing the defensibility of Nanophase’s technology. The company also highlighted that its Day Mode Hero Concealer prototype became a finalist in four industry award categories, a sign that its innovations are resonating with partners and end markets.

Manufacturing Consolidation Boosts Scale Potential

The company consolidated its operations from three manufacturing facilities to two while maintaining on-time-in-full performance for customers. Management believes current capacity can support more than $200 million in revenue without major new investment and expects six-figure annual savings from the consolidation effort.

Leadership Upgrades and ‘Transform and Transcend’ Plan

Nanophase strengthened its leadership team with the addition of a seasoned chief financial officer in September 2025 and a new vice president of brand partnerships. These changes underpin the “Transform and Transcend” program, built on four pillars: operational excellence, technology-driven expansion, capturing more value and collaborative globalization.

Short-Term Costs and Disruption from Restructuring

Q4 operating expenses increased to $3.2 million from $2.8 million, largely due to relocation-related charges tied to the footprint consolidation. Management also warned that first-quarter 2026 results will be pressured by spending on training, restructuring and changing customer order patterns as the new plan is rolled out.

Guidance Signals Margin Rebuild and Cash Focus

Looking ahead, Nanophase set a 30% gross-margin floor for 2026 and is targeting at least a five-point increase in gross profit margin by year-end relative to 2025, with EBITDA expected to return to double-digit levels. The company expects six-figure annual savings from facility consolidation, aims to boost free cash flow by reducing safety stock, plans new category launches from late Q2 or early Q3 2026 and sees a potential 10%-plus international margin improvement beginning in 2027, though it cautioned that Q1 may reflect ongoing customer softness and transformation costs.

Nanophase’s earnings call painted a company at an inflection point, combining record sales and a robust innovation engine with the hard work of fixing margins and execution. Investors will be watching closely to see if the Transform and Transcend program can convert capacity and IP strengths into sustainable profitability and free cash flow over the next few years.